Zinc-finger protein-targeted gene regulation: Genomewide single-gene specificity
Siyuan Tan,Dmitry Guschin,Albert Davalos,Ya-Li Lee,Andrew W. Snowden,Yann Jouvenot,H. Steven Zhang,Katherine Howes,Andrew R. McNamara,Albert Lai,Chris Ullman,Lindsey Reynolds,Michael Moore,Mark Isalan,Lutz-Peter Berg,Bradley Campos,Hong Qi,S. Kaye Spratt,Casey C. Case,Carl O. Pabo,Judith Campisi,Philip D. Gregory
DOI: https://doi.org/10.1073/pnas.2035056100
IF: 11.1
2003-09-26
Proceedings of the National Academy of Sciences
Abstract:Zinc-finger protein transcription factors (ZFP TFs) can be designed to control the expression of any desired target gene, and thus provide potential therapeutic tools for the study and treatment of disease. Here we report that a ZFP TF can repress target gene expression with single-gene specificity within the human genome. A ZFP TF repressor that binds an 18-bp recognition sequence within the promoter of the endogenous CHK2 gene gives a >10-fold reduction in CHK2 mRNA and protein. This level of repression was sufficient to generate a functional phenotype, as demonstrated by the loss of DNA damage-induced CHK2-dependent p53 phosphorylation. We determined the specificity of repression by using DNA microarrays and found that the ZFP TF repressed a single gene ( CHK2 ) within the monitored genome in two different cell types. These data demonstrate the utility of ZFP TFs as precise tools for target validation, and highlight their potential as clinical therapeutics.